Blinding in randomised trials: hiding who got what

[1]  I. Chalmers,et al.  The Landscape and Lexicon of Blinding in Randomized Trials , 2002, Annals of Internal Medicine.

[2]  G. Guyatt,et al.  Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. , 2001, JAMA.

[3]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[4]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[5]  A. Astrup,et al.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial , 2000, The Lancet.

[6]  R. Bellomo,et al.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.

[7]  S. Carley,et al.  An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb , 2000, BMJ : British Medical Journal.

[8]  D. Klein,et al.  Validity of clinical trials of antidepressants. , 2000, The American journal of psychiatry.

[9]  H. Williams,et al.  How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.

[10]  D. Ashby,et al.  Randomized controlled trials in cystic fibrosis (1966–1997) categorized by time, design, and intervention , 2000, Pediatric pulmonology.

[11]  T. Kaptchuk,et al.  Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine , 1998, Bulletin of the history of medicine.

[12]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[13]  U. Tamoufé,et al.  A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. , 1998, The New England journal of medicine.

[14]  International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice. , 1998, Federal register.

[15]  I. Chalmers,et al.  What is the prior probability of a proposed new treatment being superior to established treatments? , 1997, BMJ.

[16]  S. Walter,et al.  Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure. , 1996, Fertility and sterility.

[17]  R. J. Hayes,et al.  Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology , 1996, BMJ.

[18]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[19]  D G Altman,et al.  Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. , 1994, JAMA.

[20]  J. Noseworthy,et al.  The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial , 1994, Neurology.

[21]  H. Drutz,et al.  Effectiveness of antibiotic prophylaxis in preventing bacteriuria after multichannel urodynamic investigations: a blind, randomized study in 124 female patients. , 1991, American journal of obstetrics and gynecology.

[22]  D. Grimes,et al.  Preventing IUCD‐related pelvic infection: The efficacy of prophylactic doxycycline at insertion , 1991, British journal of obstetrics and gynaecology.

[23]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[24]  P. Gøtzsche.  Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.

[25]  C. Meinert.  Clinical Trials: Design, Conduct, and Analysis , 1986 .

[26]  S. Pocock,et al.  Clinical Trials: A Practical Approach , 1984 .

[27]  Frederick Mosteller,et al.  Reporting on methods in clinical trials. , 1982, The New England journal of medicine.

[28]  F. Mosteller,et al.  Reporting standards and research strategies for controlled trials , 1980 .

[29]  A randomized trial of aspirin and sulfinpyrazone in threatened stroke. , 1978, The New England journal of medicine.

[30]  A. L. Jussieu.  Rapport de l'un des commissaires chargés par le roi de l'examen du magnétisme animal , 1969 .

[31]  L. Lasagna.  The controlled clinical trial: theory and practice. , 1955, Journal of chronic diseases.

[32]  S. Wolf.  Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos. , 1950, The Journal of clinical investigation.